New Zealand Brain Research Institute
Christchurch, New Zealand
2 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 2Phase 3
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
DementiaAlzheimers DiseaseAlzheimers Disease, Familial
Washington University School of Medicine280 enrolled37 locationsNCT05552157
Recruiting
Phase 2Phase 3
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
DementiaAlzheimers DiseaseAlzheimers Disease, Familial
Washington University School of Medicine280 enrolled37 locationsNCT06647498
Recruiting
Phase 1
A Study of LY3439539 in Participants With Alzheimer's Disease
Alzheimer Disease
Eli Lilly and Company30 enrolled9 locationsNCT07598370
Recruiting
Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's Disease
Huntington’s Disease
Hoffmann-La Roche40 enrolled6 locationsNCT07246941
Recruiting
Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers
Huntington Disease
Hoffmann-La Roche600 enrolled45 locationsNCT06667414
Recruiting
Phase 1
A First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease
Huntington’s Disease
Sarepta Therapeutics, Inc.32 enrolled2 locationsNCT07536061